Overall Technical outlook

Price Summary

Alembic Pharmaceuticals Limited's stock opened at 945.0 on 2025-08-13, surged to 953.9, hit a low of 940.0, and closed up -0.24% at 942.75, with 25820 shares traded.
The stock's highest price in the past 52 weeks is 1247.7, while its lowest price during the same period is 743.65.
Analysts predict that the future price will fluctuate between 900.0 and 1345.0, with the mean expected price being approximately 1067.091.

Technicals

Support and Resistance: The price for APLLTD at 942.75 is supported by the 880.55 level and faces resistance at 952.6. This range indicates key levels where the price may find buyers near 880.55 and sellers near 952.6, defining a trading range.
APLLTD supportResistance 8f228e
Support/Resistance for APLLTD


Aroon: The current state of the AROON is neutral, providing no clear signals for either an upward or downward movement. This indicates that the market may be in a state of equilibrium, with no strong momentum in either direction.
APLLTD aroon 8f228e
Aroon chart for Alembic Pharmaceuticals Limited


Bol. Bands: The BOLL BANDS is showing a neutral reading, with no clear direction indicated for upward or downward movement. This neutral position suggests a possible period of consolidation.
APLLTD bbands 8f228e
Bolinger Bands chart for Alembic Pharmaceuticals Limited


Parabolic SAR: The PSAR continues to signal a bearish outlook, setting a significant resistance level. This resistance could limit upward momentum, indicating that the market may struggle to overcome this bearish pressure in the near term.
APLLTD psar 8f228e
Parabolic Stop and Reverse chart for Alembic Pharmaceuticals Limited


Stochastic: The current state of the STOCHASTIC is neutral, offering no clear signals of movement in either direction. This suggests a potential pause in market activity, with no strong trend emerging at the moment.
APLLTD stoch 8f228e
Stochastic chart for Alembic Pharmaceuticals Limited


Tripple Moving Agerage: The current state of the Tripple MOVING AVG is neutral, with no clear trend direction indicated. This lack of directional bias suggests that the market may be in a phase of consolidation or uncertainty.
APLLTD trippleSMA 8f228e
Tripple SMA chart for Alembic Pharmaceuticals Limited


A thorough analysis of a company involves looking beyond its stock price movements and trading patterns. You must also examine its fundamentals, which include profitability, growth prospects, and competitive advantages. Additionally, the industry in which the company operates provides important context, as factors like technological innovations, regulation, and market demand influence performance. By integrating this information with technical analysis, more accurate predictions about the company's future can be made.